Literature DB >> 21192933

Expression of S100A8/A9 in HaCaT keratinocytes alters the rate of cell proliferation and differentiation.

Andreas Voss1, Günther Bode, Claudia Sopalla, Malgorzata Benedyk, Georg Varga, Markus Böhm, Wolfgang Nacken, Claus Kerkhoff.   

Abstract

S100A8/A9 promotes NADPH oxidase in HaCaT keratinocytes and subsequently increases NFκB activation, which plays important roles in the balance between epidermal growth and differentiation. S100A8/A9-positive HaCaT cells present with a significantly reduced rate of cell division and greater expression of two keratinocyte differentiation markers, involucrin and filaggrin, than control cells. S100A8/A9 mutants fail to enhance NFκB activation, TNFα-induced IL-8 gene expression and NFκB p65 phosphorylation, and S100A8/A9-positive cells demonstrate better cell survival in forced suspension culture than mutant cells. S100A8/A9 is induced in epithelial cells in response to stress. Therefore, S100A8/A9-mediated growth arrest could have implications for tissue remodeling and repair.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21192933     DOI: 10.1016/j.febslet.2010.12.037

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  23 in total

1.  Aquaporin 3 and E-Cadherin Expression in Perilesional Vitiligo Skin.

Authors:  Ola Ahmed Bakry; Magda Mostafa Hagag; Mona Abd El Halim Kandil; Wafaa Ahmed Shehata
Journal:  J Clin Diagn Res       Date:  2016-12-01

2.  Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma.

Authors:  Ziqiang Li; Mei Tang; Bo Ling; Shiying Liu; Yu Zheng; Chunlai Nie; Zhu Yuan; Liangxue Zhou; Gang Guo; Aiping Tong; Yuquan Wei
Journal:  J Mol Med (Berl)       Date:  2013-11-27       Impact factor: 4.599

Review 3.  Novel insights into the role of S100A8/A9 in skin biology.

Authors:  Claus Kerkhoff; Andreas Voss; Thomas E Scholzen; Michelle M Averill; Kurt S Zänker; Karin E Bornfeldt
Journal:  Exp Dermatol       Date:  2012-08-09       Impact factor: 3.960

4.  Evaluation and screening of mRNA S100A genes as serological biomarkers in different stages of bladder cancer in Egypt.

Authors:  Manal F Ismail; Noha A El Boghdady; Marwa I Shabayek; Heba A Awida; Hamdy Abozeed
Journal:  Tumour Biol       Date:  2015-10-27

Review 5.  Joining S100 proteins and migration: for better or for worse, in sickness and in health.

Authors:  Stephane R Gross; Connie Goh Then Sin; Roger Barraclough; Philip S Rudland
Journal:  Cell Mol Life Sci       Date:  2013-06-30       Impact factor: 9.261

6.  Biomarkers of neonatal skin barrier adaptation reveal substantial differences compared to adult skin.

Authors:  Marty O Visscher; Andrew N Carr; Jason Winget; Thomas Huggins; Charles C Bascom; Robert Isfort; Karen Lammers; Vivek Narendran
Journal:  Pediatr Res       Date:  2020-06-29       Impact factor: 3.756

Review 7.  Neutrophils in Tumorigenesis: Missing Targets for Successful Next Generation Cancer Therapies?

Authors:  Fabrice Tolle; Viktor Umansky; Jochen Utikal; Stephanie Kreis; Sabrina Bréchard
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

8.  S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma.

Authors:  Claudia Maletzki; Peggy Bodammer; Anne Breitrück; Claus Kerkhoff
Journal:  Hepat Mon       Date:  2012-10-12       Impact factor: 0.660

9.  Molecular interface of S100A8 with cytochrome b558 and NADPH oxidase activation.

Authors:  Sylvie Berthier; Minh Vu Chuong Nguyen; Athan Baillet; Marc-André Hograindleur; Marie-Hélène Paclet; Benoît Polack; Françoise Morel
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

10.  S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma.

Authors:  Ali Khammanivong; Chengxing Wang; Brent S Sorenson; Karen F Ross; Mark C Herzberg
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.